NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.77
+0.91 (3.05%)
At close: Mar 9, 2026, 4:00 PM EDT
30.90
+0.13 (0.42%)
After-hours: Mar 9, 2026, 4:12 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.54 billion as of March 9, 2026. Its market cap has increased by 73.93% in one year.
Market Cap
3.54B
Enterprise Value
2.73B
1-Year Change
73.93%
Ranking
Category
Stock Price
$30.77
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.54B, an increase of 2,190.58%. That is a compound annual growth rate of 85.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.43B | -13.69% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.81B |
| Centessa Pharmaceuticals | 3.79B |
| ACADIA Pharmaceuticals | 3.78B |
| ADMA Biologics | 3.67B |
| Corcept Therapeutics | 3.60B |
| Legend Biotech | 3.50B |
| Xenon Pharmaceuticals | 3.49B |
| Alumis | 3.35B |